Response to Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced Oral Cancer
Conditions: Oral Cancer Interventions: Drug: PD-1 inhibitor+carboplatin+albumin-bound paclitaxel Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abraxane | Cancer | Cancer & Oncology | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Oral Cancer | Research